Clinical Trial Update: Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial comparing BM-MSC and AT-MSC for spinal cord injuries across Phase 1 and Phase 2, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• AT-MSC (adipose tissue–derived mesenchymal stem cells)
• BM-MSC (bone marrow–derived mesenchymal stem cells)

Snippet

Sponsor: University of Jordan | Conditions: Spinal Cord Injuries | Phase 1, Phase 2 | Status: COMPLETED